Tag: RET proto-oncogene

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to RET proto-oncogene

Fidelity Special Values Plc - Total Voting Rights

Added to Collection on: 2021-07-01 14:48:45

Tags for this article:

Drugs
Chemical compounds
Health sciences
Breakthrough therapy
Orphan drugs
Tyrosine kinase receptors
Lung cancer
Medullary thyroid cancer
RET inhibitor
RET proto-oncogene
Papillary thyroid cancer
Thyroid cancer
DOW JONES INDUSTRIAL AVERAGE INDEX
Roche Group
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Roche announces FDA approval of Gavreto (pralsetinib) for people with advanced or metastatic ...

Added to Collection on: 2020-12-02 06:00:00

Tags for this article:

Thyroid cancer
Drugs
Chemical compounds
Health sciences
Breakthrough therapy
Orphan drugs
Tyrosine kinase receptors
Lung cancer
Medullary thyroid cancer
RET inhibitor
RET proto-oncogene
Papillary thyroid cancer
DOW JONES INDUSTRIAL AVERAGE INDEX
Roche Group
Basel
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Roche, Blueprint catch up with Lilly as Gavreto snags FDA thyroid cancer nod

Added to Collection on: 2020-12-02 16:54:40

Tags for this article:

Anatomy
Branches of biology
Thyroid cancer
Tyrosine kinase receptors
Breakthrough therapy
Orphan drugs
Medullary thyroid cancer
Endocrine system
RET proto-oncogene
RET inhibitor
Pralsetinib
Papillary thyroid cancer

Click the tags to see associated articles and topics

View Article Details
Global Non Receptor Tyrosine Protein Kinase TYK2 Market Research Report 2021-2025 || Array ...

Added to Collection on: 2021-01-16 11:19:03

Tags for this article:

Tyrosine kinases
Enzymes
Branches of biology
Tyrosine kinase receptors
Signal transduction
Tyrosine kinase 2
Tyrosine kinase
Cerdulatinib
Protein kinase
TEC
RET proto-oncogene

Click the tags to see associated articles and topics

View Article Details
Roche's Gavreto Conditionally Approved In Europe For RET Fusion-Positive Lung Cancer

Added to Collection on: 2024-04-05 23:39:49

Tags for this article:

Lung cancer
Orphan drugs
Tyrosine kinase receptors
RET proto-oncogene
RET inhibitor
Non-small-cell lung cancer
Pralsetinib
Antineoplastic drugs
Roche Holdings AG

Click the tags to see associated articles and topics

View Article Details
Book a Demo